FDA releases FAQs on new requirements for medical devices vulnerable to cybersecurity threats
Effective today under the Consolidated Appropriations Act of 2023, medical devices seeking approval from the Food and Drug Administration must meet certain cybersecurity requirements if they connect to the internet and contain software and technological characteristics vulnerable to cybersecurity threats. See the FDA FAQs for more on the requirements.
Related News Articles
Headline
The National Security Agency, Cybersecurity and Infrastructure Security Agency and international partners released joint guidance Oct. 30 on best practices for…
Headline
Microsoft issues security update addressing critical vulnerability impacting Windows server services
Microsoft has released a security update to address a critical remote code execution vulnerability impacting multiple versions of Windows Server Update…
Headline
In part two of a recent blog, AHA National Advisor for Cybersecurity and Risk John Riggi and AHA Deputy National Advisor for Cybersecurity and Risk Scott Gee…
AHA Cyber Intel
In part one of this blog, we reviewed the number of cyberattacks the health care field endured this year compared to last; provided an overview of the lessons…
Headline
The Cybersecurity and Infrastructure Security Agency Oct. 15 released an emergency directive advising federal agencies to take stock of their F5 BIG-IP…
Headline
In part one of a new blog, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk,…